{
    "code": 0,
    "data": [
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "c486237a-dda3-4ec9-995a-a99d41a31bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication on February 07 2026 with respect to the unaudited Financial results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fc8dba1-0879-40b6-8c4a-4fdb6ac2552d.pdf",
            "news_date": "2026-02-07 16:24:13"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "news_id": "8f7f1999-d117-4abc-aeec-946f8b9bd1dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56d4b8f1-0961-4159-8c1d-1ddee8378747.pdf",
            "news_date": "2026-02-06 18:33:45"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about copy of Newspaper publication with respect to Second reminder for payment of the First Call money - Rights issue (Partly paid shares)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4668db9-8320-4bd0-9012-b523685b6a7d.pdf",
            "news_date": "2026-02-06 15:56:42"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation in funds raised through Rights issue for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f242718-9284-403a-b6f4-7bb36c3613bc.pdf",
            "news_date": "2026-02-06 14:36:48"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies.",
            "news_body": "The Company has reviewed and adopted the revised \" Policy for Determining Materiality of Events/Information for Disclosure to the Stock Exchanges\" and \"Policy for Governance of Related Party Transactions\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad97f977-6219-4de8-9143-f958bd383d44.pdf",
            "news_date": "2026-02-06 14:24:10"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Press release dated February 06 2026 titled \"Solara Announces Q326 Financial Results.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0374765f-df10-426d-8fea-c7169b10261a.pdf",
            "news_date": "2026-02-06 14:07:41"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for  Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=895b38a1-0a8f-4bb5-b893-ac3fc31fd1d1.pdf",
            "news_date": "2026-02-06 13:50:35"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "news_id": "6db61019-0809-4488-b17b-0631f8f0f14c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Advertisement published with respect to dispatch of the notice of Postal Ballot dated February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3dfe2518-3939-485e-89fd-75dde57434fa.pdf",
            "news_date": "2026-02-05 18:24:24"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of Second Reminder Notice For Payment Of First Call Money",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Second Reminder Notice for payment of First call under Rights issue.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dfd4635-b92e-4555-9021-4eadda19cd0e.pdf",
            "news_date": "2026-02-04 23:10:22"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Notice of Postal Ballot dated February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e0adda2-442b-4bce-860c-9d332763cef0.pdf",
            "news_date": "2026-02-04 22:52:42"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Revised Intimation of Schedule of Analyst / Institutional Investor call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on Friday February 06 2026 at 3:30 P.M. to discuss the Companys unaudited financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73cf30f-974f-4d75-9970-605022016c2a.pdf",
            "news_date": "2026-02-03 14:59:29"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday February 06 2026 to discuss the Companys unaudited financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797c3033-9b64-4a7c-b667-0badd701137f.pdf",
            "news_date": "2026-01-30 20:27:50"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025.",
            "news_body": "Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce088b13-3f61-4ae7-94f3-c1659d4c906e.pdf",
            "news_date": "2026-01-30 19:33:59"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2607bf68-fabd-44c1-a369-c14f5d9aa2ef.pdf",
            "news_date": "2026-01-12 15:30:41"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding closure of Trading Window for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bc5bd7e-b196-42eb-aed0-1970414992ab.pdf",
            "news_date": "2025-12-24 13:01:30"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 1500 shares pursuant to exercise of ESOP options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a38a443-ad2a-4b0c-9bbb-7ac90f9b1e91.pdf",
            "news_date": "2025-12-17 11:49:35"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reconstitution Of The Management Committee",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the reconstitution of the Management Committee.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a39fb621-8abf-4ce1-8fac-bc27498f4e42.pdf",
            "news_date": "2025-12-17 11:14:27"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding appointment of Mr. Mohanraj S(DIN: 08420411) as Additional Executive Director and Whole Time Director with effect from January 01 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e8967e0-957a-43e6-be72-e8cbf203df69.pdf",
            "news_date": "2025-12-17 11:01:08"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for  Board Meeting Outcome For Solara Active Pharma Sciences Limited Held On December 17 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Board Meeting held on December 17 2025 inter alia to consider appointment of Mr. Mohanraj. S (DIN:08420411) as Additional Executive Director and Whole Time Director\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53fb5031-b6f7-4911-85d1-78501b1f89cc.pdf",
            "news_date": "2025-12-17 10:52:34"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Resignation of Mr. Mohan Muthunarayanan (DIN: 03610282)Whole Time Director & Chief Operating Officer of the company with effect from the end of business hours on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6913bca-7e10-464f-a529-e7e6e28714f9.pdf",
            "news_date": "2025-12-05 18:14:08"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Volume Movement",
            "news_body": "Clarification in relation to the mail received from exchange on December 04 2025 on Volume Movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ce663b2-80e6-4c9e-9dad-ab98a88b7800.pdf",
            "news_date": "2025-12-04 13:50:10"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Solara Active Pharma Sciences Ltd",
            "news_body": "The Exchange has sought clarification from Solara Active Pharma Sciences Ltd on December 04 2025 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-12-04 12:53:56"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the Press release titled \"Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore facility with continued state of compliance on cGMP.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28b667e5-dc09-4162-b483-e8b65fc61c41.pdf",
            "news_date": "2025-11-19 10:19:40"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "news_id": "0b6b15c4-4df3-4589-8793-029ea0e032f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publications w.r.t. Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43130d62-6a3c-4a00-a869-57e8350c0845.pdf",
            "news_date": "2025-11-06 19:02:25"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e404eba8-7d41-4eeb-bfa5-f07ac06d3ae7.pdf",
            "news_date": "2025-11-06 18:25:55"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "news_id": "5c08553e-7e19-4362-9678-1114df43c82a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:50"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General-Updates",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the following items approved at the Board Meeting held on November 05 2025: \r\n\r\n1. Appointment of Mr. Sarat Kumar Asuri CFO as the Chief Investor Relations Officer.\r\n\r\n2. Change in remuneration of the Whole Time Director Mr. Mohan Muthunarayanan.\r\n\r\n3. Change in the remuneration of the eligible Senior Management Personnels.\r\n\r\n4. Review and confirmation of Risk Management Policy.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66f76cc5-79a6-4f5f-8d1f-9196fa286fbf.pdf",
            "news_date": "2025-11-05 15:38:21"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 8040 Equity shares pursuant to the exercise of ESOP Options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0eba826-b98f-40d3-bbc9-b4c3589e5634.pdf",
            "news_date": "2025-11-05 15:19:23"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation in Funds raised through Rights Issue for the quarter ending September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8937b40c-4fdb-4e42-9070-793158dc5bac.pdf",
            "news_date": "2025-11-05 15:16:14"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding The Grant Of ESOP",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the grant of 25000 Employee Stock Options under Solara Employee Stock Option Scheme 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee639b10-d70c-499e-bc9a-680f638a24e8.pdf",
            "news_date": "2025-11-05 15:02:10"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation About Appointment Of Mr. Mohanraj S As Chief Human Resources Officer (CHRO)",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Mohanraj S as Chief Human Resources Officer (CHRO) and designated him as Senior Management Personnel with effect from November 05 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab71aa26-c5d9-4352-bfd2-db6d3de0b2f4.pdf",
            "news_date": "2025-11-05 14:50:56"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated November 05 2025 titled \"Solara Q226 Performance\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b27a99c9-58ce-4cba-bff2-6095b3027384.pdf",
            "news_date": "2025-11-05 14:44:18"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Resignation of Non Executive Non Independent Director Mr. Kartheek Chintalapati Raju w.e.f the end of business hours of November 05 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98179e13-cf69-4a71-980f-e474e6f82b57.pdf",
            "news_date": "2025-11-05 14:31:27"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "news_id": "3e5d66cf-2767-4e6e-8907-4f364f729420",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the Analyst / Investors call to be held on Wednesday November 052025 at 15.30 P.M. IST to discuss the Companys unaudited financial results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=119ca60b-c47b-43e1-84c5-9ba62b341450.pdf",
            "news_date": "2025-10-30 21:49:51"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve unaudited financial results of the Company for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fbbb8a2-3700-4424-ab35-73197305677e.pdf",
            "news_date": "2025-10-29 16:08:37"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By CRISIL",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the ESG rating received from Crisil ESG Ratings & Analytics Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5405a967-e6b3-41b8-94af-d5838ce6134c.pdf",
            "news_date": "2025-10-17 11:19:39"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9a2c897-fd59-4f84-88c7-8e22a34cea89.pdf",
            "news_date": "2025-10-16 15:55:05"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of shares pursuant to exercise of ESOP Options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cc3cd76-a765-4132-aec4-7cadba714620.pdf",
            "news_date": "2025-10-13 23:57:24"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the Newspaper publication regarding Intimation of 100 days campaign - \"Saksham Niveshak\" and Notice Intimating the shareholders about the opening of a special window for Re - lodgement of transfer requests of physical shares and request for KYC updation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d385d45-7353-442c-8a3b-a5e6fce7fd8a.pdf",
            "news_date": "2025-10-09 17:49:37"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Stock exchange regarding the Voting Results and Scrutinizers Report of the 8th Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb3baf0f-e3c3-4df7-a266-ee32adaf0f31.pdf",
            "news_date": "2025-09-29 17:19:13"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the closure of Trading Window for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e79afa18-7000-4b55-ad7d-af7526c08cfc.pdf",
            "news_date": "2025-09-26 21:46:26"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 SEBI (LODR) - Clarification",
            "news_body": "Clarification in relation to mail received from BSE on Volume Movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdc905b2-ca51-4bc2-b223-84f1dcbf596c.pdf",
            "news_date": "2025-09-26 14:00:22"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Solara Active Pharma Sciences Ltd",
            "news_body": "The Exchange has sought clarification from Solara Active Pharma Sciences Ltd on September 26 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-09-26 12:52:59"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Solara Active Pharma Sciences Limited - Proceedings of the Eighth Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56fddd72-7d63-41ef-b9c1-975a96ef7f58.pdf",
            "news_date": "2025-09-25 20:02:09"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mitsubishi UFJ Financial Group (MUFG)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9BE474DE_5612_4B46_800C_7ABD0672D5DB_130449.pdf",
            "news_date": "2025-09-04 13:04:54"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Post Dispatch Newspaper Publication of 8th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2673aa72-8aed-4241-9fb4-84f373a07f4e.pdf",
            "news_date": "2025-09-03 16:23:45"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Post Dispatch Newspaper Publication of 8th AGM Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f674319-d5bd-48c7-ae01-72b07e7cd73b.pdf",
            "news_date": "2025-09-03 16:10:48"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the financial year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bbffa58-b59b-4de4-8e6d-13b9dfcd0aef.pdf",
            "news_date": "2025-09-02 21:30:10"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=570e7d90-62b4-4036-87a2-8db374479e32.pdf",
            "news_date": "2025-09-02 21:24:18"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of The 8Th Annual General Meeting",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of 8th Annual General Meeting (\"AGM\") of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f87743b3-f6de-4161-a650-1a527d24e7b9.pdf",
            "news_date": "2025-09-02 21:05:44"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Stock Exchange regarding the Newspaper Publication with respect to Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fe5d6f4-27e0-4504-b4b0-a231abed893c.pdf",
            "news_date": "2025-09-01 17:18:58"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding 100 Days Campaign - Saksham Niveshak",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding intimation to shareholders as per the 100 Days Campaign - \"Saksham Niveshak\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e2bd4e-7232-4284-b555-b4b94731c354.pdf",
            "news_date": "2025-08-21 19:05:25"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of Call Money Pursuant To The First Reminder Notice Issued For Payment Of First Call Money On The Outstanding Partly Paid-Up Rights Equity Shares Of The Company.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the receipt of first call money pursuant to the First Reminder Notice issued for payment of first call money on the outstanding partly paid Rights Equity Shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361b198f-ccbe-4da7-9a51-ed49acf79dcf.pdf",
            "news_date": "2025-08-16 13:05:26"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended June 30 2025 received from CRISIL Ratings Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c408e53b-b4b2-4c19-8280-dce74d9f7d1e.pdf",
            "news_date": "2025-08-13 15:56:40"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "news_id": "7f1a498a-c178-4311-9a09-2fb864d8fe0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Newspaper publication made on July 26 2025 wherein the Financial Results for the quarter ended June 30 2025 has been published.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b971ac89-70c3-490f-8eba-162daea2af82.pdf",
            "news_date": "2025-07-26 16:36:00"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about Link of Recording of the Investors meet held on 25th July 2025 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4629c965-465b-4690-a330-612c95b3a6bc.pdf",
            "news_date": "2025-07-25 18:43:06"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated July 25 2025 titled   \" Solara Q1 26 Performance\" of the Board Meeting held today i.e. July 25 2025 to consider the unaudited financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7608b701-8298-43fb-b889-9762cce8f6cc.pdf",
            "news_date": "2025-07-25 15:25:11"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights issue for Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75db47d5-0ece-4b76-acfd-4ef2cae259cb.pdf",
            "news_date": "2025-07-25 13:40:16"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "news_id": "bd9762a2-d030-4c7b-9f48-76402b1ab1e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with Limited review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46d6b9c-f2f7-46f8-91a2-a85f4d39bb69.pdf",
            "news_date": "2025-07-25 13:19:12"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of Investors/Analyst call to be held on Friday 25th July 2025 at 4.00P.M.  to discuss the Companys financial results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0e57803-5046-4fb4-833c-47ec8277a6e3.pdf",
            "news_date": "2025-07-21 16:57:22"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Quarter Ended June 30 2025 Under SEBI Listing Regulations",
            "news_body": "Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 inter alia to consider and approve unaudited standalone and consolidated Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14fc3c21-40a4-48ba-8805-8b1e87a91301.pdf",
            "news_date": "2025-07-18 17:35:55"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb8cd94a-05e9-4edf-b8bb-5aeda69fa848.pdf",
            "news_date": "2025-07-17 17:35:36"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "This is to inform that Solara Active Pharma Sciences Limited has made a Newspaper Publication on July 05 2025 as a reminder to encash the unpaid Sale proceed of Fractional Shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f3ce8f-b290-42ad-a268-7553082a189b.pdf",
            "news_date": "2025-07-07 16:52:14"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the copy of the Newspaper publication made by the Company with respect to dispatch of first reminder notice for payment of First Call Money",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f8751b-1e06-4383-b8f4-219d775d94d6.pdf",
            "news_date": "2025-07-03 14:40:33"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of First Reminder Notice For Payment Of First Call Money",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the dispatch of First Reminder Notice for payment of First Call Money sent on July 01 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c91a7f-f7c0-488e-87d4-001f19710557.pdf",
            "news_date": "2025-07-02 11:49:12"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Solara Active Pharma Sciences Limited has informed Stock Exchange regarding Credit Rating received from Crisil Ratings Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7782219c-d0dc-4da5-a925-0dcee307ef02.pdf",
            "news_date": "2025-07-01 17:19:46"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Solara Active Pharma Sciences Limited has informed the stock exchange regarding the Trading Window Closure with effect from July 01 2025 pursuant to SEBI(Prohibition of Insider Trading) Regulations 2015 for considering the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a65ea5f8-4965-4520-ac48-b434778ef495.pdf",
            "news_date": "2025-06-27 15:34:57"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pronomz Ventures LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3F126460_48CF_4E72_9C83_5CF1EC07E39C_172754.pdf",
            "news_date": "2025-06-17 17:27:57"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Newspaper publication for transfer of unclaimed shares to IEPF account",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74d92a3c-1b7d-4843-8fc2-7139bb10e371.pdf",
            "news_date": "2025-05-28 17:35:23"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the submission of Annual Secretarial Compliance report for the year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7152c15e-a66e-4635-a648-5e78bee3654d.pdf",
            "news_date": "2025-05-28 17:31:05"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "news_id": "a5c08d85-75d8-41ec-917f-cf9361b9b6c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited hereby informed the exchange on the newspaper publication made on May 16 2025 wherein the Financial Results for the quarter and year ended March 31 2025 were published.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab77fef6-523a-42ae-81fe-0ab7e0c3a399.pdf",
            "news_date": "2025-05-16 13:26:47"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the outcome of the Investors conference call for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0a43c95-b207-4809-a69a-3287d23632e0.pdf",
            "news_date": "2025-05-15 19:43:17"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Internal Auditors Secretarial Auditor And Reappointment Of Cost Auditor.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Appointment of Internal Secretarial Auditor and Reappointment of Cost Auditor in the Board Meeting held on May 15 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02a59773-2cff-4408-a743-979c3749203f.pdf",
            "news_date": "2025-05-15 17:30:00"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment of Company Secretary Compliance officer and Key Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e817c667-e6db-4947-a4ca-13359becfe42.pdf",
            "news_date": "2025-05-15 17:14:34"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Retirement",
            "caption": "Announcement under Regulation 30 (LODR)-Retirement",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Retirement of Company Secretary and Compliance officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=116cf05e-1cb4-478c-87c2-6d5d09af546f.pdf",
            "news_date": "2025-05-15 17:11:11"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding Resignation and Appointment of Company Secretary and Compliance officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85d3daa9-d661-470d-be71-9793bd962bfe.pdf",
            "news_date": "2025-05-15 16:55:16"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights Issue for Quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e715b48-e062-4b82-bbbf-0fcd30379fc9.pdf",
            "news_date": "2025-05-15 16:43:41"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Press Release for the Board Meeting held on May 15 2025 on Q4 of FY 25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b77fcb83-d70c-4b22-88a5-3d62939d6795.pdf",
            "news_date": "2025-05-15 16:41:25"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding inter alia the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors Report for the said period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ff50430-af28-4caf-a9ff-6708c3da02f5.pdf",
            "news_date": "2025-05-15 14:26:11"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "news_id": "1112947a-3f13-45da-9975-3b3664efc16f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 - Press Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the press release of completion of USFDA Inspection in Ambernath facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e6cf5f-61dc-45c1-9228-19873722a95f.pdf",
            "news_date": "2025-05-10 15:40:33"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday May 15 2025 at 3:30 PM to discuss the Companys Financial results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd45bff9-f7cb-4eb3-917d-294f5cead860.pdf",
            "news_date": "2025-05-08 12:53:32"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Board Meeting Intimation",
            "news_body": "Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve Audited standalone and consolidated Financial Results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56569785-1099-4166-a4e3-f9c4c0cc45ae.pdf",
            "news_date": "2025-05-07 15:02:50"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended March 31 2025 received from CRISIL Ratings Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0556508-77bd-41aa-a3ec-a0cf28757920.pdf",
            "news_date": "2025-05-07 13:13:06"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For The Rights Issue Committee Meeting - Receipt Of First Call Money",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Outcome of Rights Issue Committee Meeting -Receipt of the First Call Money in connection with the shares issued on Rights Basis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca045740-0502-416e-a9fb-8503fee70176.pdf",
            "news_date": "2025-05-06 15:44:39"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Corporate Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Corporate Office Address",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Corporate Office address.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c248ed0-5c28-475e-a0e9-03144f8aa80f.pdf",
            "news_date": "2025-05-05 14:59:13"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in the Registered Office of the Company within the local limits of the City.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3bd0410-c118-4ba3-8e46-d6a75d2eaa02.pdf",
            "news_date": "2025-05-05 14:55:16"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Incorporation Of Wholly Owned Subsidiary Company",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Incorporation of Wholly Owned Subsidiary Company in the name of \"Synthix Global Pharma Solutions Limited\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee259107-7772-46b1-bb8a-fee679d21d2b.pdf",
            "news_date": "2025-04-29 16:18:25"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b33f6925-2058-42f4-8196-3e5ed9f32111.pdf",
            "news_date": "2025-04-17 15:54:59"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about Copy of the Newspaper publications made by the Company on the Record date fixed for the purpose of dispatch of the First Call Notice to the eligible shareholders",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e409f7-eccf-4a00-844b-371cc92a721c.pdf",
            "news_date": "2025-04-09 13:35:34"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Notice On The First Call Money Of The Rights Equity Shares.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Notice to the eligible shareholders of the First Call Money of the Rights Equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8239b84e-d5b5-4bbd-99f6-becff944353d.pdf",
            "news_date": "2025-04-09 13:34:19"
        },
        {
            "co_code": 70281,
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Rights Issue Committee Meeting_Solara Active Pharma Sciences Limited",
            "news_body": "Outcome: Solara Active Pharma Sciences Limited informed the exchange about the Rights Issue Committee Meeting held today (i.e.) on April 02 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4483179-8603-4614-991d-ca0f4b4b9c91.pdf",
            "news_date": "2025-04-02 15:59:58"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on January 24 2025.",
            "news_id": "57350834-8043-401b-bfaa-be048f28415a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf",
            "news_date": "2025-01-31 14:57:07",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31 2024 and other matters.",
            "news_id": "bf17eecf-e153-43e6-b025-d77f2fec053d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf",
            "news_date": "2025-01-24 14:46:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on October 21, 2024",
            "news_id": "4a9a3f82-066f-45c6-b681-93b86826b9d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b29a992d-d676-4e46-a1e4-d1623da7cd2f.pdf",
            "news_date": "2024-10-28 11:34:24",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con Call Audio Recording",
            "news_id": "c2c3c45e-ef63-422a-859e-6b9eaf8722b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e806b6-1e0a-4f1f-bb94-5789ac2d4bb6.pdf",
            "news_date": "2024-10-21 19:17:57",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Solara Active pharma Sciences Limited has informed the Exchange regarding Board meeting held on October 21, 2024 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024 and allotment of 49,000 equity shares pursuant to exercise of ESOP granted under SOLARA ESOP Plan 2018",
            "news_id": "e4d4b103-6462-4ed3-a1ee-9e2cbcffc85c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af90b8a4-b506-40d0-b910-0c45407e4c37.pdf",
            "news_date": "2024-10-21 14:29:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the con-call held on July 22, 2024",
            "news_id": "0e19026b-ef5f-405a-9f14-f07b41730a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea196c2-01af-416f-aa85-aec959bae507.pdf",
            "news_date": "2024-07-26 20:13:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con Call Audio Recording",
            "news_id": "863dbb2e-0c7f-471e-8b12-261026a9518a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aad8b0a7-e412-4454-8363-1ad5e184be3d.pdf",
            "news_date": "2024-07-22 17:28:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited financial results for the quarter ended June 30, 2024",
            "news_id": "552636e2-6c1e-4d1d-93b6-2a18528a98ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc7b7e11-3628-4a24-b267-9c82aded4f0e.pdf",
            "news_date": "2024-07-22 14:04:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited financial results for the quarter ended June 30, 2024",
            "news_id": "d20634e1-cb43-421d-a6d4-17c782e58197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7310d508-be51-4fc7-9413-2425c6822806.pdf",
            "news_date": "2024-07-22 14:02:19",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call held for the quarter ended March 31, 2024",
            "news_id": "673ccf8e-9f10-43a3-88df-a7b54cf54fdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5271c7c0-9763-407d-bb53-ddc965891340.pdf",
            "news_date": "2024-06-04 11:53:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con-call Audio recording for the Investor call held on May 29, 2024.",
            "news_id": "ab565791-c291-4377-9fe7-1890bcd79297",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554bed00-d888-4035-a012-557700f22602.pdf",
            "news_date": "2024-05-29 17:36:23",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Period Ended March 31, 2024",
            "news_body": "Results for the period ended March 31, 2024",
            "news_id": "623b54fd-5418-4ba5-a9d8-625d35808dae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8112e42a-0564-403e-b8df-5dfcd8c3a0cd.pdf",
            "news_date": "2024-05-29 15:36:23",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call for the quarter ended December 31, 2023.",
            "news_id": "8ebc48c5-9edc-44b8-bfa2-4388e7e5e70b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25957af6-ed81-4e1b-9198-841881e86c50.pdf",
            "news_date": "2024-02-21 10:36:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con-call audio recording held to discuss Q3 FY24 Unaudited Financial Results.",
            "news_id": "1e0143eb-44f3-4cd9-838e-0ca8887887ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1a5b4f7-4d77-49c9-9fc4-33f5d4df690a.pdf",
            "news_date": "2024-02-14 18:49:58",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended December 31, 2023.",
            "news_body": "Unaudited Financial Results for the period ended December 31, 2023",
            "news_id": "bd7be511-0ac5-42c6-ae7b-f599c2947dfa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feb3922a-2794-425b-ae95-2b25fa62fa7f.pdf",
            "news_date": "2024-02-14 14:03:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript of the call held on November 14, 2023",
            "news_id": "2acb9ac2-3619-42f5-ab35-1236ebe60a7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b75ef5e-68ef-4eed-b743-ff697809dcf7.pdf",
            "news_date": "2023-11-20 20:11:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (LODR), we hereby confirm that we have uploaded audio recording of the Q2 of FY24 earnings call held on November 14, 2023, on our company website.",
            "news_id": "6044678c-8098-46c7-8005-13d6a181e254",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea4bbc9e-f695-4dce-bc8a-2389d1d8c9f4.pdf",
            "news_date": "2023-11-14 18:07:47",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended September 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended September 30, 2023",
            "news_id": "79cff787-0207-4774-895b-4955d0bb81b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c7b7ca-fca3-4aed-8856-32576711b1f2.pdf",
            "news_date": "2023-11-14 15:03:58",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR), please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2023, conducted after the meeting of Board of Directors held on August 14, 2023, for your information and records.",
            "news_id": "d2d0b39f-387e-442b-bc1d-a6eeb8d8b5d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e2d10ec-499b-4ae8-be64-bce0671e9a4f.pdf",
            "news_date": "2023-08-21 14:22:43",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (LODR) we wish to inform that we have uploaded audio recording of the Q1 of FY24 earnings call held on August 14, 2023, on our company website.",
            "news_id": "0cef4f19-ad08-435a-a011-54b8d80f5332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8a2ef3-2829-4680-bebf-b1b45f532b36.pdf",
            "news_date": "2023-08-14 17:04:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2023 along with limited review report and press release is attached.",
            "news_id": "3cdb5ee3-c1b6-4c84-8256-9a7b8fdecd10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=837a4a4c-bff6-4114-a1f9-a94be52960fb.pdf",
            "news_date": "2023-08-14 14:00:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended March 31, 2023, conducted after the meeting of Board of Directors held on May 12, 2023, for your information and records.",
            "news_id": "42bd6fb5-b47c-4160-925a-1a56d73efc9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0996d757-2036-48b8-ba9b-d8a26cdf0c3c.pdf",
            "news_date": "2023-05-18 19:09:57",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 of FY23 Earnings Call held on May 12, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.",
            "news_id": "5e5c9f8f-7abb-4260-9824-0151fdfa5200",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ace3ff6-d2dd-4baf-8105-4946a3ffeb2d.pdf",
            "news_date": "2023-05-12 18:42:52",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited financial results (standalone and consolidated) of the Company for the quarter and Year ended March 31, 2023, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2023, along with the Auditors report for the said period and press release on the same is attached.",
            "news_id": "fe24ab47-5f42-488e-b7ba-3240e4657be6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62bc3310-db79-4a9a-b98f-d8cfa21cbd6d.pdf",
            "news_date": "2023-05-12 14:32:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclose the transcript of the earnings conference call for the quarter ended December 31, 2022, conducted after the meeting of Board of Directors held on January 25, 2023, for your information and records.",
            "news_id": "142f299c-cf2c-459e-8dd6-75af250dde05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f869ef58-2b4c-4813-9612-43ae3e927fb8.pdf",
            "news_date": "2023-02-01 13:23:17",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q3 of FY23 Earnings Call held on January 25, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.",
            "news_id": "1a0be46f-1762-4e8a-a5d3-b68fc850f411",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8283aab4-3ba7-4262-918a-f6abcaa00d94.pdf",
            "news_date": "2023-01-25 18:36:53",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 25, 2023",
            "news_body": "Outcome of Board Meeting held on January 25, 2023",
            "news_id": "4830a3cc-5c1f-48f0-8d47-74934e531c98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dafb3b8-a939-4cc9-b90f-25c6b9857c3b.pdf",
            "news_date": "2023-01-25 14:16:48",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31, 2022.",
            "news_body": "Unaudited financial results (standalone and consolidated) of the Company for the quarter ended December 31, 2022. A copy of the unaudited financial results (standalone andconsolidated) for the quarter ended December 31, 2022, along with the Limited Review Report by the Auditors and press release is attached.",
            "news_id": "bcd3802a-e62a-40c3-911f-562fe92d472f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9227091f-ea5f-43ac-9c25-298924893330.pdf",
            "news_date": "2023-01-25 13:56:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions For The Half Year Ended September 30, 2022",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, we hereby enclose disclosure on Related Party Transactions, for the half year ended September 30, 2022.",
            "news_id": "aae6cb69-d7c1-41cf-8cf2-6f7131b4e137",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71d5beb0-8bdc-4e53-acea-a2e6166da4a4.pdf",
            "news_date": "2022-11-21 17:23:26",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended September 30, 2022, conducted after the meeting of Board of Directors held on November 9, 2022",
            "news_id": "5c65376c-9679-457d-b923-e1d1c1036f3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0933b48-babc-4e7b-83a2-aeeb447275e3.pdf",
            "news_date": "2022-11-15 14:52:05",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q2 of FY23 Earnings Call held on November 9, 2022, on our Company website",
            "news_id": "ef9ae282-3995-4724-84c4-859771976e2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aec98359-96f8-40f3-80e0-526019e46638.pdf",
            "news_date": "2022-11-09 18:38:25",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended September 30, 2022",
            "news_body": "We wish to inform that meeting of Board of Directors of the company held today (i.e., November 9, 2022), the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure<BR> Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) along with the Limited Review Report by the Auditors and press release is attached.",
            "news_id": "4b37592e-128f-4188-be9b-713cc8519d15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1462de29-e37a-4e27-8869-82dc71cfb34c.pdf",
            "news_date": "2022-11-09 13:31:42",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the Earnings Call held on August 4, 2022.",
            "news_id": "a2cc9693-0bb3-4a8f-991e-2ec78af127e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77ec6862-2ae3-4d11-87a4-47344f55c38e.pdf",
            "news_date": "2022-08-10 13:10:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022 Along With Limited Review Report And Press Release.",
            "news_body": "Unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2022, along with the Limited Review Report<BR> by the Auditors and press release is attached.",
            "news_id": "c849a338-5e06-43e5-afb8-c49b7c56460a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=786e9c06-a2c4-45d3-ae98-382be4cf2517.pdf",
            "news_date": "2022-08-04 13:50:49",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Period Ended March 31, 2022",
            "news_body": "Disclosure Of Related Party Transactions For The period Ended March 31, 2022",
            "news_id": "18ddb620-2c5f-4d1c-b7f9-9ad8ed23ac65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5995e23-1da1-4007-8d69-e37ce3ef52e1.pdf",
            "news_date": "2022-05-13 13:17:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2022, conducted after the meeting of Board of Directors held on April 29, 2022, for your information and records.",
            "news_id": "fac6e86c-5219-4fae-ad4a-7d785911b1d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6653f98-4599-4eeb-ac08-fa90a4604dd5.pdf",
            "news_date": "2022-05-06 13:58:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached updated Investor Presentation and request you to take the same on record.",
            "news_id": "62bf1ad0-238a-4943-9dc5-21445d2fda75",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=482d92d7-1b2d-4f9e-816f-9977b5325375.pdf",
            "news_date": "2022-05-02 11:55:12",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirmthat we have uploaded audio recording of the Q4 of FY22 Earnings Call held on April 29, 2022, on our Company website",
            "news_id": "a5b68f31-08c0-484c-b165-7dd9ea9ee5c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6849150e-8805-40bc-838a-3df179644841.pdf",
            "news_date": "2022-04-30 11:05:20",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Andyear Ended March 31, 2022 Pursuant To Regulation 33 Of SEBI (Listing Obligations Anddisclosure Requirements) Regulation, 2015. A Copy Of The Audited Financial Results(Standalone And Consolidated) For The Quarter And Year Ended March 31, 2022 Along With<BR> The Auditors Report For The Said Period And Press Release On The Same Is Attached",
            "news_body": "Audited financial results (standalone and consolidated) of the Company for the quarter andYear ended March 31, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations andDisclosure Requirements) Regulation, 2015. A copy of the audited financial results(standalone and consolidated) for the quarter and year ended March 31, 2022 along with<BR> the Auditors report for the said period and press release on the same is attached",
            "news_id": "af16356d-dd17-4834-9d7e-f69e7066af2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16f4defd-391b-4b70-8e26-9e7be479cb56.pdf",
            "news_date": "2022-04-29 15:06:16",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Financial results for the period ended december 31st, 2021",
            "news_id": "000297d3-96de-4eae-93c0-5122e8dabcf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80d0bd27-ec8a-40f8-bdf8-dc03994d86be.pdf",
            "news_date": "2022-02-09 16:07:32",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Half Year Ended September 30, 2021.",
            "news_body": "We wish to inform that meeting of Board of Directors of Solara Active Pharma Sciences Limited ('Company') held today (i.e., November 11, 2021), the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.<BR>",
            "news_id": "fd9bd78e-2da3-4b9f-946a-7b7cc7ce11e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6b2f7f6-6ec7-41e4-9563-93fdf02bbf62.pdf",
            "news_date": "2021-11-11 14:42:31",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Update - Intimation of Analysts / Institutional Investors Conference Call.<BR> <BR> Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Thursday, November 11, 2021, to discuss its Q2 financial results.",
            "news_id": "dc4cbeca-3505-467b-ac73-c54cc7797a84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cc3f300-b79a-486c-8718-f1c3dfbd3b6c.pdf",
            "news_date": "2021-11-09 13:27:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Thursday, November 11, 2021, to discuss its Q2 financial results.",
            "news_id": "826f0e79-1eba-47a8-9c47-1c5daaa25a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f95e76c-a792-4839-a062-c4a041ca6ca6.pdf",
            "news_date": "2021-11-08 16:13:33",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Please refer our letter dated July 28, 2021 under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in continuation we wish to inform that at the meeting of Board of Directors held today (August 4, 2021) the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2021.",
            "news_id": "f17dd423-5276-4e9d-98cc-a72b608ee4b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=153e336e-fb60-4be5-b4c4-270a36349be0.pdf",
            "news_date": "2021-08-04 14:16:01",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Wednesday, August 4, 2021 to discuss its Q1 financial results.",
            "news_id": "c734172a-e995-4fc6-9f71-0e8a657fd9e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497a94be-eb48-46c6-8010-ed168e82f94f.pdf",
            "news_date": "2021-07-28 12:09:43",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Year Ended March 31, 2021",
            "news_body": "Disclosure of Related party transactions for the year ended March 31, 2021",
            "news_id": "44520acf-e307-4a85-b00a-57e24886d137",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=142275a3-8146-41a2-94d9-67b9d647eb7e.pdf",
            "news_date": "2021-06-03 13:58:52",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company will be participating in the virtual investor conference on May 25, 2021, organised by Spark capital.",
            "news_id": "bb4f9b38-c8cd-4e19-b7e9-7d398282e053",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2632d123-0d07-4615-87cb-231e07b011cd.pdf",
            "news_date": "2021-05-24 13:54:35",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company will be participating in the virtual annual investor conference today i.e May 19, 2021, organised by DAM Capital Advisors limited.",
            "news_id": "cb00c3ff-3d54-4dcd-b43a-ea62e1d5ea2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08059b4e-4e90-4672-ab0f-cc93bb06d094.pdf",
            "news_date": "2021-05-19 10:49:32",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For March 31, 2021.",
            "news_body": "Results - Financial Results for March 31, 2021.",
            "news_id": "372b0f34-192f-4737-b5c6-39fff6942a9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc8d7ec3-dea7-4bb1-81fd-7a08aa0c86ed.pdf",
            "news_date": "2021-05-06 15:13:44",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors / Analysts on Thursday 6th May 2021, 3:30 pm IST to discuss on Q4 results.",
            "news_id": "60cab3a8-fb9f-4156-980f-559f8b481650",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7f1b33b-55e2-4aaf-924c-9393fd0a7cd5.pdf",
            "news_date": "2021-04-30 17:11:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor presentation issued by the Company titled:<BR> 'ACCELERATING GROWTH: SOLARA AND AURORE MERGE TO BECOME INDIA'S SECOND LARGEST PURE PLAY API / CRAMS COMPANY'",
            "news_id": "7179bd15-ff1a-40e2-8269-c08fa3aec289",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc4b8d50-2534-4280-b790-322869dd102d.pdf",
            "news_date": "2021-04-11 17:01:19",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "UPDATE - conference call with the Investors / Analysts on Monday 12th April 2021, 9:00 am IST -  with updated link for the call.",
            "news_id": "53d3ca71-8f10-4c05-9edc-cd77e515c90b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f9761c-956b-497f-93b2-4120457e9a6f.pdf",
            "news_date": "2021-04-09 20:48:13",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors / Analysts on Monday 12th April 2021, 9:00 am IST.",
            "news_id": "af28ac67-ff95-4968-8a8b-75023a1679de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=838bc498-80e4-429c-a274-54d73bd5b6d6.pdf",
            "news_date": "2021-04-09 19:39:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}